Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-term study of SYR-322
jRCT2080221603Phase 3
- Sponsor
- Takeda
- Start
- Oct 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-arm trial of alogliptin in type 2 diabetes mellitus (T2DM), sponsored by Takeda.
02
Drugs
alogliptin
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCT2080221603.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221603.